Charles River Laboratories International Inc (MEX:CRL)
MXN 3917.07 0 (0%) Market Cap: 200.20 Bil Enterprise Value: 250.74 Bil PE Ratio: 24.84 PB Ratio: 2.99 GF Score: 71/100

Charles River Laboratories International Inc at Evercore ISI HealthCONx Conference Transcript

Dec 02, 2020 / 02:40PM GMT
Elizabeth Hammell Anderson
Evercore ISI Institutional Equities, Research Division - Associate

Hi, everybody. Thanks for joining us today. I'm Elizabeth Anderson. I'm the health care technology and distribution analyst here at Evercore. And I'm very pleased to be joined by Jim Foster, who is the CEO of Charles River Labs. Just before we get started, I just wanted to point out that there is a separate question panel. So if you have a question that you want me to weave into my questions, feel free to put it there, and I will do that.

On that note, Jim, please take it away.

James C. Foster
Charles River Laboratories International, Inc. - Chairman, CEO & President

Thanks, Elizabeth. Just a quick sort of summary of where we're at. We reported a really strong third quarter, up almost 8% with our operating margin almost to 23%, which was a really strong quarter. EPS up almost 40%. We did increase our revenue guidance to 5% to 6%, which we're pleased with. I do want to clarify the fact that, while we're pleased to have COVID-related work, it's only about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot